Top Abstract Purchase Related
Home
>
Node
>
Subnode

Longterm methotrexate therapy in rheumatoid arthritis: a review

Kremer, J.M.

Journal of Rheumatology. Suppl 12(Suppl 12): 25-28

1985

ISSN/ISBN: 0380-0903
PMID: 3913773
Document Number: 258009
A review of the literature on the longterm use of methotrexate in patients with rheumatoid arthritis (RA) showed that many questions on protocol remain unanswered. Although rheumatologists have adopted certain guidelines previously followed by dermatologists for psoriasis patients, rheumatology literature offers no set of rules for using the drug in treating patients with RA. The use of liver function tests and liver biopsy specimens to predict and assess hepatotoxicity associated with methotrexate use is also discussed.

Document emailed within 1 workday
Secure & encrypted payments

Kerstens, P.J.; Boerbooms, A.M.; Jeurissen, M.E.; de Graaf, R.; Mulder, J.; van de Putte, L.B. 2000: Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine Journal of Rheumatology 27(5): 1148-1155
Furst, D.E.; Erikson, N.; Clute, L.; Koehnke, R.; Burmeister, L.F.; Kohler, J.A. 1990: Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis Journal of Rheumatology 17(12): 1628-1635
Morgan, S.L.; Baggott, J.E. 2010: Folate supplementation during methotrexate therapy for rheumatoid arthritis Clinical and Experimental Rheumatology 28(5 Suppl. 61): S102-S109
Jardine, D.L.; Colls, B.M. 2002: Hodgkin's disease following methotrexate therapy for rheumatoid arthritis New Zealand Medical Journal 115(1156): 293-294
Frizen, B.N.; Dormidontov, E.N. 1992: The efficacy of basic therapy in rheumatoid arthritis with methotrexate Terapevticheskii Arkhiv 64(5): 34-36
Biasi, D.; Bambara, L.M.; Carletto, A.; Casaril, M.; Capra, F.; Caramaschi, P.; Corrocher, R. 1996: Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate Journal of Rheumatology 23(3): 453-454
Leeb, B.; Dunky, A.; Ogris, E.; Wohanka, A.; Schenk, G.; Gaismayer, K.; Eberl, R. 1989: Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritis International Journal of Clinical Pharmacology Research 9(3): 209-215
Sewerin, P.; Müller-Lutz, A.; Abrar, D.Benjamin.; Odendahl, S.; Eichner, M.; Schneider, M.; Ostendorf, B.; Schleich, C. 2019: Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis Clinical and Experimental Rheumatology 37(2): 179-185
Shinozawa, T.; Kameda, H.; Hama, N.; Yoshida, T.; Ohosone, Y.; Ichikawa, Y. 1998: The efficacy of combination therapy with prednisolone (PSL) and methotrexate (MTX) on radiographic progression in patients with rheumatoid arthritis (RA) Ryumachi 38(1): 14-22
Tajima, Y.; Yabe, N.; Morishige, S.; Tamura, E.; Sakimoto, Y.; Takenoya, T.; Oto, I.; Yoshikawa, T.; Osumi, K.; Murai, S. 2019: A Case of Small Bowel Perforation Caused by Malignant Lymphoma after Methotrexate Therapy for Rheumatoid Arthritis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(4): 736-738
Biasi, D.; Caramaschi, P.; Carletto, A.; Pacor, M.L.; Bambara, L.M. 1997: Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis Revue du Rhumatisme 64(7-9): 521-522
Ferraccioli, G.; Casatta, L.; Bartoli, E. 1996: Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy Journal of Rheumatology 23(9): 1539-1542
Madhok, R.; Torley, H.I.; Capell, H.A. 1991: A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis Journal of Rheumatology 18(10): 1485-1489
Krause, D.; Gabriel, B.; Herborn, G.; Braun, J.; Rau, R. 2015: Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis Clinical and Experimental Rheumatology 33(5): 611-616
Antoni, C.; Kalden, J.R. 1999: Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 17(6 Suppl 18: S73-S77
Champion, G.D.; Cairns, D.R.; Bieri, D.; Adena, M.A.; Browne, C.D.; Cohen, M.L.; Day, R.O.; Edmonds, J.P.; Graham, G.G.; de Jager, J. 1988: Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis Journal of Rheumatology 15(1): 28-34
Paulus, H.E.; Johnston, K.R.; Lachenbruch, P.A. 1992: Practice based evaluation of the longterm benefit of second line agents in rheumatoid arthritis Journal of Rheumatology. Suppl 32: 80-84
Ronkainen, A.; Niskanen, M.; Auvinen, A.; Aalto, J.; Luosujärvi, R. 2006: Cervical spine surgery in patients with rheumatoid arthritis: longterm mortality and its determinants Journal of Rheumatology 33(3): 517-522
Moens, H.J.; Ament, B.J.; Feltkamp, B.W.; van der Korst, J.K. 1987: Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens Journal of Rheumatology 14(6): 1115-1119
Cleland, L.G.; Caughey, G.E.; James, M.J.; Proudman, S.M. 2006: Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis Journal of Rheumatology 33(10): 1973-1979